Ledger.Open graph →
SEC Form D · filed January 4, 2016

Lodo Therapeutics Corp

Offering
$3.7M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

David J. Mcelligott · New York, NYExec · PromoterJoel J. Marcus · New York, NYDirectorAsish Xavier · New York, NYDirectorM. J. Erwin · New York, NYDirectorDavid J. Schubert · New York, NYExec · PromoterBarbara J. Dalton · New York, NYDirectorJames J. Sullivan · New York, NYDirectorLindsay J. Rayle · New York, NYExec · PromoterMisti J. Ushio · New York, NYDirectorSteve Gillis · New York, NYDirectorThong Le · New York, NYExec · Director · PromoterWilliam P. Dambrackas · Weston, FLDirectorFernando E. Alcoceer · Vancouver, British Columbia, CanadaExec · Director · PromoterBryan Darroch · Grand Cayman, Cayman IslandsDirectorNancy R. Fuller · Linden, TXDirectorWilliam D. Pruitt · Coral Gables, FLDirectorHoward C. Glick · Linden, TXDirectorLindsay J. Rayle · New York, NYExec · PromoterDavid J. Mcelligott · New York, NYExec · PromoterJane E. Trust · Baltimore, MDDirectorRichard F. Sennett · Baltimore, MDExec · Director · PromoterThomas C. Mandia · Stamford, CTExec · Director · PromoterBenjamin E. Seidlich · Baltimore, MDExec · PromoterRobert I. Frenkel · Stamford, CTExec · PromoterS. C. Bain · Phoenix, AZDirectorJay E. Wolf · Phoenix, AZDirectorLawrence D. Bain · Phoenix, AZDirectorDavid E. Smith · Phoenix, AZDirectorMarc Rubenstein · Phoenix, AZExec · PromoterGeorge Mccabe · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗